148 related articles for article (PubMed ID: 23391006)
1. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach.
Posner HB; Cano S; Carrillo MC; Selnes O; Stern Y; Thomas RG; Zajicek J; Hobart J;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S56-60. PubMed ID: 23391006
[TBL] [Abstract][Full Text] [Related]
2. Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods.
Hobart J; Cano S; Posner H; Selnes O; Stern Y; Thomas R; Zajicek J;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S4-9. PubMed ID: 23253777
[TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
4. Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.
Hobart J; Cano S; Posner H; Selnes O; Stern Y; Thomas R; Zajicek J;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S10-20. PubMed ID: 23253779
[TBL] [Abstract][Full Text] [Related]
5. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.
Cano SJ; Posner HB; Moline ML; Hurt SW; Swartz J; Hsu T; Hobart JC
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1363-8. PubMed ID: 20881017
[TBL] [Abstract][Full Text] [Related]
6. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
7. New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.
Verma N; Beretvas SN; Pascual B; Masdeu JC; Markey MK;
Alzheimers Res Ther; 2015 Nov; 7(1):64. PubMed ID: 26560146
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
[TBL] [Abstract][Full Text] [Related]
9. The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials.
Raghavan N; Samtani MN; Farnum M; Yang E; Novak G; Grundman M; Narayan V; DiBernardo A;
Alzheimers Dement; 2013 Feb; 9(1 Suppl):S21-31. PubMed ID: 23127469
[TBL] [Abstract][Full Text] [Related]
10. Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater s' Perceptions.
Meyer SM; Bertzos KA; Perez M; Connor DJ; Schafer K; Walter S
Curr Alzheimer Res; 2017; 14(9):1008-1016. PubMed ID: 28413982
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
[TBL] [Abstract][Full Text] [Related]
12. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
13. Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease.
Wesnes K; Edgar C; Andreasen N; Annas P; Basun H; Lannfelt L; Zetterberg H; Blennow K; Minthon L
Acta Neurol Scand; 2010 Oct; 122(4):270-7. PubMed ID: 20047570
[TBL] [Abstract][Full Text] [Related]
14. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.
Coley N; Andrieu S; Jaros M; Weiner M; Cedarbaum J; Vellas B
Alzheimers Dement; 2011 Nov; 7(6):602-610.e2. PubMed ID: 21745761
[TBL] [Abstract][Full Text] [Related]
15. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
[TBL] [Abstract][Full Text] [Related]
16. Adaptation and validation of the Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog) in a low-literacy setting in sub-Saharan Africa.
Paddick SM; Kisoli A; Mkenda S; Mbowe G; Gray WK; Dotchin C; Ogunniyi A; Kisima J; Olakehinde O; Mushi D; Walker RW
Acta Neuropsychiatr; 2017 Aug; 29(4):244-251. PubMed ID: 28345494
[TBL] [Abstract][Full Text] [Related]
17. Development of novel measures for Alzheimer's disease prevention trials (NoMAD).
Bell SA; Cohen HR; Lee S; Kim H; Ciarleglio A; Andrews H; Rivera AM; Igwe K; Brickman AM; Devanand DP; Harvey PD; Schneider LS; Goldberg TE
Contemp Clin Trials; 2021 Jul; 106():106425. PubMed ID: 33933666
[TBL] [Abstract][Full Text] [Related]
18. Psychometric comparison of standard and computerized administration of the Alzheimer’s Disease Assessment Scale: Cognitive Subscale (ADASCog).
O'Halloran JP; Kemp AS; Salmon DP; Tariot PN; Schneider LS
Curr Alzheimer Res; 2011 May; 8(3):323-8. PubMed ID: 21314622
[TBL] [Abstract][Full Text] [Related]
19. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
Kueper JK; Speechley M; Montero-Odasso M
J Alzheimers Dis; 2018; 63(2):423-444. PubMed ID: 29660938
[TBL] [Abstract][Full Text] [Related]
20. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
